BioCentury | Nov 15, 2012
Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Cystic fibrosis (CF) Poly(ADP-ribose) polymerase-3 (PARP-3) Cell culture and mouse studies suggest antagonizing PARP-3 could be useful for treating CF. In a cell culture...
Items per page:
1 - 1 of 1